Breaking News

BioMagnetic Solutions to Build cGMP Production Facility at Penn State

Site is expected to be fully operational in mid-2022 with more than 13,000 sq.-ft. of purpose-built office, lab, and cGMP manufacturing space.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Gamma Biosciences, a global life sciences company focused on advanced therapies, announced its portfolio company BioMagnetic Solutions (BMS) has signed a lease with GLP Development to build a cGMP-grade production facility in Innovation Park at Penn State. The site is expected to be fully operational in mid-2022 with more than 13,000 sq.-ft. of purpose-built office, laboratory, and cGMP manufacturing space. ISO 13485 and ISO 9001:2015 certifications have also been achieved to ensure the highest ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters